<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Walker C</submitter><funding>American Heart Association</funding><funding>National Natural Science Foundation of China</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>167123</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8409435</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>433(18)</volume><pubmed_abstract>Somatic mutations in the PRKACA gene encoding the catalytic α subunit of protein kinase A (PKA-C) are responsible for cortisol-producing adrenocortical adenomas. These benign neoplasms contribute to the development of Cushing's syndrome. The majority of these mutations occur at the interface between the two lobes of PKA-C and interfere with the enzyme's ability to recognize substrates and regulatory (R) subunits, leading to aberrant phosphorylation patterns and activation. Rarely, patients with similar phenotypes carry an allosteric mutation, E31V, located at the C-terminal end of the αA-helix and adjacent to the αC-helix, but structurally distinct from the PKA-C/R subunit interface mutations. Using a combination of solution NMR, thermodynamics, kinetic assays, and molecular dynamics simul</pubmed_abstract><journal>Journal of molecular biology</journal><pubmed_title>Is Disrupted Nucleotide-Substrate Cooperativity a Common Trait for Cushing's Syndrome Driving Mutations of Protein Kinase A?</pubmed_title><pmcid>PMC8409435</pmcid><funding_grant_id>R01 GM100310</funding_grant_id><funding_grant_id>22007069</funding_grant_id><funding_grant_id>R35 GM130389</funding_grant_id><funding_grant_id>20PRE35120253</funding_grant_id><funding_grant_id>S10 OD021536</funding_grant_id><funding_grant_id>GM100310</funding_grant_id><funding_grant_id>R01 GM046736</funding_grant_id><funding_grant_id>GM046736</funding_grant_id><pubmed_authors>Bernlohr DA</pubmed_authors><pubmed_authors>Veglia G</pubmed_authors><pubmed_authors>Olivieri C</pubmed_authors><pubmed_authors>Walker C</pubmed_authors><pubmed_authors>Gao J</pubmed_authors><pubmed_authors>Taylor SS</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Calebiro D</pubmed_authors><pubmed_authors>V S M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Is Disrupted Nucleotide-Substrate Cooperativity a Common Trait for Cushing's Syndrome Driving Mutations of Protein Kinase A?</name><description>Somatic mutations in the PRKACA gene encoding the catalytic α subunit of protein kinase A (PKA-C) are responsible for cortisol-producing adrenocortical adenomas. These benign neoplasms contribute to the development of Cushing's syndrome. The majority of these mutations occur at the interface between the two lobes of PKA-C and interfere with the enzyme's ability to recognize substrates and regulatory (R) subunits, leading to aberrant phosphorylation patterns and activation. Rarely, patients with similar phenotypes carry an allosteric mutation, E31V, located at the C-terminal end of the αA-helix and adjacent to the αC-helix, but structurally distinct from the PKA-C/R subunit interface mutations. Using a combination of solution NMR, thermodynamics, kinetic assays, and molecular dynamics simul</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2026-05-31T02:17:53.561Z</modification><creation>2024-10-16T04:17:31.343Z</creation></dates><accession>S-EPMC8409435</accession><cross_references><pubmed>34224748</pubmed><doi>10.1016/j.jmb.2021.167123</doi></cross_references></HashMap>